86
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Relative indoleamine 2,3-dioxygenase transcript level concerning anti-HBs titers in response to HBV vaccination in hemodialysis patients

, , , &
Pages 947-953 | Received 07 May 2018, Accepted 20 Sep 2018, Published online: 01 Oct 2018

References

  • Mast EE, Weinbaum CM, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory committee on immunization practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep. 2006;55(RR–16):1–33. quiz CE1-4.
  • Grzegorzewska AE, Świderska MK, Warchoł W. Antibodies to hepatitis B virus surface antigen and survival of hemodialysis patients - a prospective study. Expert Rev Vaccines. 2016;15(8):1063–1074.
  • Hernández-Bernal F, Aguilar-Betancourt A, Aljovin V, et al. Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults. Hum Vaccin. 2011;7(10):1026–1036.
  • Pan L, Zhang W, Liang Z, et al. Association between polymorphisms of the cytokine and cytokine receptor genes and immune response to hepatitis B vaccination in a Chinese Han population. J Med Virol. 2012;84(1):26–33.
  • Milich DR, Leroux-Roels GG. Immunogenetics of the response to HBsAg vaccination. Autoimmun Rev. 2003;2(5):248–257.
  • Girndt M, Sester U, Sester M, et al. The interleukin-10 promoter genotype determines clinical immune function in hemodialysis patients. Kidney Int. 2001;60(6):2385–2391.
  • Grzegorzewska AE, Wobszal PM, Mostowska A, et al. Antibodies to hepatitis B virus surface antigen and interleukin 12 and interleukin 18 gene polymorphisms in hemodialysis patients. BMC Nephrol. 2012;13:75.
  • Pesanti EL. Immunologic defects and vaccination in patients with chronic renal failure. Infect Dis Clin North Am. 2001;15(3):813–832.
  • Fernández E, Betriu MA, Gómez R, et al. Response to the hepatitis B virus vaccine in haemodialysis patients: influence of malnutrition and its importance as a risk factor for morbidity and mortality. Nephrol Dial Transplant. 1996;11(8):1559–1563.
  • Zitt E, Sprenger-Mähr H, Knoll F, et al. Vitamin D deficiency is associated with poor response to active hepatitis B immunisation in patients with chronic kidney disease. Vaccine. 2012;30(5):931–935.
  • Potula R, Poluektova L, Knipe B, et al. Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis. Blood. 2005;106(7):2382–2390.
  • Munn DH. Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation. Curr Opin Immunol. 2006;18(2):220–225.
  • Harrington L, Srikanth CV, Antony R, et al. Deficiency of indoleamine 2,3-dioxygenase enhances commensal-induced antibody responses and protects against Citrobacter rodentium-induced colitis. Infect Immun. 2008;76(7):3045–3053.
  • Eleftheriadis T, Liakopoulos V, Antoniadi G, et al. Indoleamine 2,3-dioxygenase is increased in hemodialysis patients and affects immune response to hepatitis B vaccination. Vaccine. 2011;29(12):2242–2247.
  • Eleftheriadis T, Sparopoulou T, Antoniadi G, et al. Suppression of humoral immune response to hepatitis B surface antigen vaccine in BALB/c mice by 1-methyl-tryptophan co-administration. Daru. 2011;19(3):236–239.
  • Grzegorzewska AE, Winnicka H, Warchoł W, et al. Correlations of indoleamine 2,3-dioxygenase, interferon-λ3, and anti-HBs antibodies in hemodialysis patients. Vaccine. 2018 Jul 16; 36(30):4454–4461. doi:10.1016/j.vaccine.2018.06.034.
  • Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol. 2004;4(10):762–774.
  • Tellmann G. The E-method: A highly accurate technique for gene-expression analysis. Nature Methods. 2006;3:i–ii.
  • Eleftheriadis T, Pissas G, Antoniadi G, et al. Increased Indoleamine 2,3-Dioxygenase in monocytes of patients on hemodialysis. Iran J Kidney Dis. 2016;10(2):91–93. PMID: 26921751.
  • Munn DH, Sharma MD, Hou D, et al. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest. 2004;114(2):280–290.
  • Pertovaara M, Raitala A, Juonala M, et al. Indoleamine 2,3-dioxygenase enzyme activity correlates with risk factors for atherosclerosis: the cardiovascular risk in young finns study. Clin Exp Immunol. 2007;148(1):106–111.
  • Wirleitner B, Rudzite V, Neurauter G, et al. Immune activation and degradation of tryptophan in coronary heart disease. Eur J Clin Invest. 2003;33(7):550–554.
  • Frick B, Schroecksnadel K, Neurauter G, et al. Increasing production of homocysteine and neopterin and degradation of tryptophan with older age. Clin Biochem. 2004;37(8):684–687.
  • Pertovaara M, Raitala A, Lehtimäki T, et al. Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality. Mech Ageing Dev. 2006;127(5):497–499.
  • Hickson M. Malnutrition and ageing. Postgrad Med J. 2006;82(963):2–8.
  • Chertow GM, Johansen KL, Lew N, et al. Vintage, nutritional status, and survival in hemodialysis patients. Kidney Int. 2000;57(3):1176–1181.
  • Brown CM, Donlon S, O’Kelly P, et al. A prospective study of hepatitis B vaccination - a comparison of responders versus nonresponders. Ren Fail. 2011;33(3):276–279.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.